Enforcement Report - Week of December 6, 2023
Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.
Hetero lab III's Generic Naproxen Receives Apprival in the U.S
Products: Prescription and non-prescription non-steroidal anti-inflammatory drugs (NSAIDs)
Novitium Pharma`s Generic Naproxen Receives Approval in US
Amneal Pharmaceuticals Generic Naproxen Receives Approval in US
Homegrown pharma major Lupin Ltd on March 5 said it has launched its generic version of Vimovo tablets, used for relief from arthritis, in the US market.
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the first-to-market launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets, a therapeutic equivalent generic version of Vimovo® (Naproxen and Esomeprazole Magnesium) Delayed-Release Tablets approved by the U.S. Food and Drug Administration (USFDA).
Sciegen Pharms Generic Naproxen Receives Approval In US
Mylan Pharms Generic Esomeprazole Magnesium; Naproxen Receives Tentative Approval in US